Metis Global Partners LLC Buys Shares of 175,140 Healthpeak Properties, Inc. (NYSE:DOC)

Metis Global Partners LLC bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the third quarter, HoldingsChannel.com reports. The institutional investor bought 175,140 shares of the real estate investment trust’s stock, valued at approximately $4,005,000.

Other large investors have also recently bought and sold shares of the company. KBC Group NV bought a new stake in Healthpeak Properties in the 3rd quarter valued at $17,438,000. Huntington National Bank boosted its position in shares of Healthpeak Properties by 2,022,900.0% during the 3rd quarter. Huntington National Bank now owns 20,230 shares of the real estate investment trust’s stock valued at $463,000 after purchasing an additional 20,229 shares in the last quarter. Arjuna Capital acquired a new stake in shares of Healthpeak Properties in the 3rd quarter valued at about $277,000. Oppenheimer & Co. Inc. acquired a new stake in shares of Healthpeak Properties in the 3rd quarter worth about $957,000. Finally, Oppenheimer Asset Management Inc. purchased a new position in Healthpeak Properties during the third quarter worth about $15,984,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 1.8 %

Shares of NYSE DOC opened at $21.25 on Friday. The business’s 50 day moving average price is $22.30 and its 200-day moving average price is $21.03. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The company has a market cap of $14.86 billion, a price-to-earnings ratio of 45.21, a PEG ratio of 2.41 and a beta of 1.13.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. During the same period in the previous year, the company posted $0.45 earnings per share. The business’s revenue for the quarter was up 25.9% on a year-over-year basis. On average, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be given a $0.30 dividend. The ex-dividend date is Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.65%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 255.32%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DOC. Citigroup boosted their price objective on Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their target price for the stock from $20.00 to $28.00 in a report on Monday, October 21st. Wells Fargo & Company reiterated an “equal weight” rating and set a $23.00 price target (up previously from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. Finally, Royal Bank of Canada upped their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, five have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $22.86.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.